Business
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across the United States. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across the United States. This momentum directly supports the Company's strategy to accelerate global growth and expand patient access to advanced, minimally invasive therapies.","length":444,"tagName":"p"},{"type":"image","alt":"Baird Medical (PRNewsfoto/Baird Medical LLC)","displaySize":"","headline":null,"caption":"Baird Medical (PRNewsfoto/Baird Medical LLC)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":58,"url":"https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0DcKXI1awHhZus7cyztYjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/89184118f4af4c585e7c535395abe2bc","width":400,"height":58}},"href":"https://mma.prnewswire.com/media/2539350/Baird_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Reinforcing the Company's market leadership in the western United States, Samer Nakhle, M.D., FACE, ECNU, Medical Director of Palm Medical Group in Las Vegas, Nevada, recently leveraged Baird Medical's technology for benign thyroid applications. His work secures broader adoption of these innovative treatments across diverse practice environments.","length":356,"tagName":"p"},{"type":"text","content":"Sophie Dream, M.D., MPH, FACS, Associate Professor and Chief of the Section of Endocrine Surgery at the University of Alabama at Birmingham, drives this national momentum forward. She utilized Baird Medical's platforms to address benign thyroid conditions, empowering the broader medical community to adopt highly effective, tissue-sparing interventions.","length":358,"tagName":"p"},{"type":"text","content":""Integrating our systems into leading academic and private practices drives our core mission," stated Mark Saxton, US CEO of Baird Medical. "These recent milestones validate our commercial roadmap and ensure more physicians have the tools necessary to elevate patient care."","length":294,"tagName":"p"},{"type":"text","content":"About Baird Medical ","length":1...